Get to Know AmerisourceBergen’s Chief Strategy Officer, Leslie Donato

FiercePharma sits down with AmerisourceBergen’s Leslie Donato, Chief Strategy Officer, to discuss her new role at the company and a brief overview of the programs offered and solutions they are bringing to customers every day.

 

Read more on

Suggested Articles

BMS' Opdivo-Yervoy combo is playing in an increasingly crowded space. But the company is leaning on new long-term data to set its regimen apart.

GSK and Alcon have pulled off prescription-to-OTC switches in hopes of giving aging brands Voltaren and Pataday a boost.

Sanofi didn't hesitate to enter Zika vaccine R&D, and despite the associated scandal, the company is again jumping into emerging disease vaccine R…